ODYLIA

odylia-logo

Odylia is a nonprofit organization that specializes in biotechnology with life-changing treatments for people with genetic diseases.

#SimilarOrganizations #People #Website #More

ODYLIA

Social Links:

Industry:
Biotechnology Genetics Health Care

Address:
Atlanta, Georgia, United States

Country:
United States

Website Url:
http://www.odylia.org

Total Employee:
1+

Status:
Active

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics


Similar Organizations

enzyvant-sciences-logo

Enzyvant Sciences

Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.


Current Advisors List

luk-vandenberghe_image

Luk Vandenberghe Member Board Of Directors & Founder @ Odylia
Board_member
2017-11-01

Current Employees Featured

ashley-winslow_image

Ashley Winslow
Ashley Winslow Chief Scientific Officer @ Odylia
Chief Scientific Officer
2019-09-01

scott-dorfman_image

Scott Dorfman
Scott Dorfman CEO @ Odylia
CEO
2017-02-01

Official Site Inspections

http://www.odylia.org Semrush global rank: 5.88 M Semrush visits lastest month: 1.41 K

  • Host name: ds27.tvsecure.com
  • IP address: 66.160.181.92
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Odylia"

Get Involved - Odylia

As a 501(c)3 nonprofit organization, Odylia offers a unique opportunity for funders and supporters to join us in bringing promising new treatments to people living with rare genetic diseases. โ€ฆSee details»

SUPPORT US - Odylia

Odylia, a 501(c)3 nonprofit organization, offers a premier opportunity for donors and philanthropists seeking change in the treatment of rare retinal diseases, advancements related โ€ฆSee details»

Odylia Therapeutics - Facebook

Odylia Therapeutics is a nonprofit biotech accelerating drug development for rare diseases Log In ... More. Posts. About. Photos. Videos. Odylia Therapeutics. About. Contact and basic info. โ€ฆSee details»

Odylia Therapeutics - LinkedIn

Odylia utilizes a unique, nonprofit business model to accelerate the development of gene therapies for people with rare disease. Our ultimate goal is to bring life changing treatments to people ...See details»

Scientists, Advocates Team Up to Launch Odylia Therapeutics to ...

New nonprofit organization will bring treatments to clinical trial for people at risk for blindness due to ultra-rare inherited retinal diseases. Boston, Mass. โ€” Scientists and advocates today โ€ฆSee details»

Odylia Therapeutics Inc - GuideStar Profile

Donate at odylia.org Ruling year info. 2018. CEO & CSO Ashley Winslow PhD. Main address. 830 Glenwood Ave SE Suite 510-323 ... Legal name of organization: Odylia Therapeutics. EIN for โ€ฆSee details»

Scientists, Advocates Team Up to Launch Odylia Therapeutics to ...

Feb 28, 2018 New nonprofit organization will bring treatments to clinical trial for people at risk for blindness due to ultra-rare inherited retinal diseases. ... For more information, please visit โ€ฆSee details»

Odylia | Our Mission

Odylia utilizes a unique, nonprofit business model to accelerate the development of gene therapies for people with rare disease, changing the way treatments are brought from the lab to the clinic. ... Reach out to learn how we can partner โ€ฆSee details»

Odylia - Crunchbase Company Profile & Funding

Odylia is a nonprofit organization that specializes in biotechnology with life-changing treatments for people with genetic diseases. Atlanta, Georgia, United States; 1-10; Private; odylia.org ; โ€ฆSee details»

Odylia Therapeutics Company Profile | Management and

Odylia was established in 2017 with support from Massachusetts Eye and Ear and the Usher 2020 Foundation, a charitable organization focused on finding cures for rare eye diseases. โ€ฆSee details»

Foundation for Angelman Syndrome Therapeutics | FAST

Before joining Odylia, Ashley worked in the Precision Medicine and Human Genetics and Computational Biomedicine group at Pfizer and the Orphan Disease Center at the University โ€ฆSee details»

New partnership with Odylia Therapeutics - Cloves Syndrome โ€ฆ

Oct 22, 2021 Through this partnership, Odylia will provide scientific and strategic guidance regarding the current state of research and clinical progress towards treatments for people โ€ฆSee details»

Odylia | About Odylia

Odylia was founded by Scott Dorfman, a successful entrepreneur and the father of two children with Usher syndrome, a rare genetic disease that affects vision and hearing, and Luk โ€ฆSee details»

Rating for Odylia Therapeutics Inc. - Charity Navigator

Odylia Therapeutics Inc. has earned a 3/4 Star rating on Charity Navigator. This Charitable Organization is headquartered in Atlanta, GA.See details»

Odylia Therapeutics - VentureRadar

Odylia is a unique nonprofit biotech bringing life-changing treatments to people with rare genetic disorders, regardless of prevalence or commercial interest. We help groups navigate the โ€ฆSee details»

Combat Clara's Blindness - Every.org

Odylia Therapeutics is a nonprofit biotech working to accelerate the development of treatments for people with rare diseases. Small organization. odylia.org. Supporters. Raised. $730. Goal โ€ฆSee details»

reImagine - Odylia

Odylia Therapeutics is a nonprofit organization working in a traditionally profit-driven space. Odylia develops genetic-targeting treatments for rare diseases using a highly focused and โ€ฆSee details»

Help Find a Cure for Anders' Eyesight - Every.org

In our search for hope and a potential cure, we learned about Odylia, an 501(c)3 organization that is making remarkable strides in the field of gene therapy specifically targeting the gene that โ€ฆSee details»

The Challenge Odyliaโ€™s Mission

1447 Peachtree St NE 7th Floor, Atlanta, GA 30309 Odylia.org. Title: Microsoft Word - Odylia Overview One Pgr6.21.21.docx Created Date: 2/23/2022 2:56:07 PM ...See details»

linkstock.net © 2022. All rights reserved